Catalogue
Mouse anti Human CD4 FITC - HLADR PE
Catalog number: B4DR$374.00
Add To CartProduct Type |
Bi-Testª Reagents (FITC/RPE) |
Units | 100 Tests |
Host | Mouse |
Species Reactivity |
Human |
Application |
Flow Cytometry |
Background
CD4 identifies human helper/inducer T cells expressing the 60,000 M.W. surface antigen (HLA class II reactive). CD4 is present in low density on monocytes. HLA-DR identifies human B cell and T cell subsets associated with approximately 10% of peripheral blood lymphocytes 28-34,000 M.W. surface antigen, also low density on monocytes and macrophages.
Synonyms: CD4 FITC - HLADR PE
Source
Immunogen: CD4=Derived from the hybridization of mouse NS-1 myeloma cells with spleen cells from BALB/c mice immunized with human perherial blood T lymphocytes.
Product
Product Form: Bi-Test (FITC/RPE) Reagent
Formulation: Provided as solution in phosphate buffered saline with 0.08% sodium azide and 0.2% carrier protein
Purification Method: Protein A/G Chromatography
Concentration: Titered for flow cytometry
Applications
PBMC: Add10 µl of MAB/10^6 PBMC in 100 µl PBS. Mix gently and incubate for 15 minutes at 2° to 8°C. Wash twice with PBS and analyze. WHOLE BLOOD: Add10 µl of MAB/100 µl of whole blood. Mix gently and incubate for 15 minutes at room temperature 20°C. Lyse the whole blood. Wash once with PBS and analyze. See instrument manufacturer’s instructions for Lysed Whole Blood and Immunofluorescence analysis with a flow cytometer or microscope.
Functional Analysis: Flow Cytometry Staining
Storage
Product should be stored at 4-8°C. DO NOT FREEZE
Product Stability: See expiration date on vial
Shipping Conditions: Room Temperature
Caution
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but our company accepts no liability for any inaccuracies or omissions in this information.
References
1. Thymus Dependent Membrane Antigens in Man: Inhibition of Cell-Mediated Lympholysis by Monoclonal Antibodies to the TH-2 Antigen. Evans, R.L., Wall, D.W., Platsoucas, C.D., Siegal, F.P., Fikrig, S.M., Testa, C.M, and Good, R.A.. Proc. Nat. Acad. Sci. 78,544,1981.
2. Novel Immunoregulatory Functions of Phenotypically Distinct Subpopulations of CD4+ cells in the Human Neonate. Clement, L.T., Vink, P.E., Bradley, G.E.. J. Immunology 145(1):102-8,1990.
3. Antigen Presentation by the CD4 Positive Monocyte Subset. Szabo, G., Miller, C.L., Kodys, K.. J. Leukoc. Biol. 47(2): 11120,1990.
4. Human Immunodeficiency Virus Infection is Efficiently Mediated by a Glycolipid-Anchored form of CD4. Diamond, D.C., Finberg, R., Chaudhuri, S., Sleckman, B.P., Burakoff, S.J.. Proc. Natl. Acad. Sci. 87(13):5001-5,1990.
5. Development Regulation of the Intrathymic T cell Precursor Population. Adkins, B., J.. Immunol. 146(5):1387-93,1991. 6. Induction of CD4 and Susceptibility to HIV-1 Infection in Human CD8+ T Lymphocytes by Human Herpesvirus
6. Lusso, P., De Maria, A., Malnati, M., Lori, F., DeRocco, S.E., Baseler, M., Gallo, R.C.. Nat. 349(6309):533-5,1991.
7. Structural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules. Karp, D.R., Teletski, C.L., Jaraquemada, D., Maloy, W.L., Coligan, J.E., Long, E.O., J. Exp.. Med. 1990 March ;171(3):615-28.
8. Trans-activation of HLA-DR gene by hepatitis B virus X gene product. Hu K.Q., Vierling J.M., Siddiqui A.. Proc. Natl. Acad. Sci. USA 1990 SEPT.; 87(18):7140-4.
9. Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. Verfaillie C., Blakolmer K., McGlave P., J. Exp. Med. 1990 Aug.: 172(2):509-2.
10. Increased circulating HLA-DR+ CD4+ T cells in systemic lupus erythematosus: alterations associated with prednisolone therapy. Raziuddin, S., Nur, M.A., Al-Wabel, A.A., Scand., Immunol. 1990 Feb.:31(2):139-45.
Protein Reference(s)
Database Name: UniProt
Accession Number: P01730, P04233
Safety Datasheet(s) for this product:
EA_Sodium Azide |